Amanda Nizam, MD· @AmandaNizamMD · X·· 2 天前评分70
正文 · 机器翻译
#ESMO26 第 1 天来了！跟随 @OncoAlert 获取全面报道！
今日 GU 肾脏与尿路上皮重点论文报告环节亮点：
🔴 3 期 KEYNOTE-866（MIBC 中 GC +/- 围手术期 pembro）
🔴 3 期 ENERGIZE（MIBC 中 GC +/- 围手术期 nivo）
🔴 1 期 TROPHYU-01 第 7 队列（1L La/mUC 中 SG + EV + Zim）
🔴 3 期 KEYNOTE-B15 的 ctDNA 分析（适合接受 cis 治疗的 MIBC 中 EV+P vs GC）
关键❓：为什么 KN-866 和 ENERGIZE 的结果为阴性，而 NIAGARA 的结果为阳性？
@scocmem @nataliagandur @DrKarineTawagi @niklas_kluemper @OncoAlert
373 浏览 · 6 赞 · 4 转发 · 0 回复
会议摘要
4735O按 Proffered paper 1: Genitourinary tumour, renal and urothelial 对上
Perioperative pembrolizumab (pembro) or placebo (pbo) + neoadjuvant cisplatin (cis) and gemcitabine (gem) in participants (pts) with muscle-invasive bladder cancer (MIBC): the double-blind, phase 3 KEYNOTE-866 study
https://esmocongress.esmo.orgThe OncoAlert #ESMO26 PULSE Faculty is ready! 🇪🇸 WE ARE HERE! Meet our incredible faculty reporting live from Madrid: @cdanicas @hoperugo @DrChoueiri @TiansterZhang @matteolambe @NiuSanford @stolaney1 @christine_lovly @amerseburger @GlopesMd @tompowles1 @montypal @Icro_Meattini @PGrivasMDPhD @brian_rini @CathyEngMD @apolo_andrea @AndreaNecchi @DrSGraff @BenWestphalen @graokane @to_be_elizabeth @ElisaAgostinett @nataliagandur @UOzkerim @DrMirallas @DrYukselUrun @Lucarecco @mzugman @HHorinouchi @p_ciracimd @DraMartinezLago @DrVilmaPBarcia @GIMedOnc @MarioBalsaMD @scocmem @AmandaNizamMD @GaiaGriguolo @JankovicK @Dr_Oncologista @Erman_Akkus @WeOncologists @niklas_kluemper @Markuseckstein3 Whether you're at #ESMO26 in Madrid or following from home, our faculty will bring you the latest science, insights, and key updates straight from the congress. OncoAlert has you covered! Less noise. No nonsense. Just science. Strictly by colleagues, for colleagues!在 X 查看被引用的帖子
来源：Amanda Nizam, MD · x.com